Radiation boost tested to shrink lung tumors before surgery
NCT ID NCT05500092
Summary
This study is for people with operable non-small cell lung cancer. It tests whether adding a precise, low-dose radiation treatment to standard pre-surgery drug therapy (immunotherapy and chemotherapy) helps shrink tumors more effectively. The goal is to see if this combined approach leads to better long-term control of the cancer after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESECTABLE STAGE IIA TO IIIB NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Montefiore Medical Center-Albert Einstein College of Medicine
The Bronx, New York, 10461, United States
-
Penn State Health Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
-
Washington University in St. Louis
St Louis, Missouri, 63130, United States
-
White Plains Hospital (WPH)
White Plains, New York, 10601, United States
Conditions
Explore the condition pages connected to this study.